{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:40:28Z","timestamp":1789681228165,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Andersen\u2013Tawil syndrome is a neurological channelopathy caused by mutations in the KCNJ2 gene that encodes the ubiquitously expressed Kir2.1 potassium channel. The syndrome is characterized by episodic weakness, cardiac arrythmias and dysmorphic features. However, the full extent of the multisystem phenotype is not well described. In-depth, multisystem phenotyping is required to inform diagnosis and guide management.<\/jats:p>\n                  <jats:p>We report our findings following deep multimodal phenotyping across all systems in a large case series of 69 total patients, with comprehensive data for 52. As a national referral centre, we assessed point prevalence and showed it is higher than previously reported, at 0.105 per 100\u2009000 population in England.<\/jats:p>\n                  <jats:p>While the classical phenotype of episodic weakness is recognized, we found that a quarter of our cohort have fixed myopathy and 13.5% required a wheelchair or gait aid. We identified frequent fat accumulation on MRI and tubular aggregates on muscle biopsy, emphasizing the active myopathic process underpinning the potential for severe neuromuscular disability. Long exercise testing was not reliable in predicting neuromuscular symptoms. A normal long exercise test was seen in five patients, of whom four had episodic weakness. Sixty-seven per cent of patients treated with acetazolamide reported a good neuromuscular response.<\/jats:p>\n                  <jats:p>Thirteen per cent of the cohort required cardiac defibrillator or pacemaker insertion. An additional 23% reported syncope. Baseline electrocardiograms were not helpful in stratifying cardiac risk, but Holter monitoring was. A subset of patients had no cardiac symptoms, but had abnormal Holter monitor recordings which prompted medication treatment. We describe the utility of loop recorders to guide management in two such asymptomatic patients. Micrognathia was the most commonly reported skeletal feature; however, 8% of patients did not have dysmorphic features and one-third of patients had only mild dysmorphic features.<\/jats:p>\n                  <jats:p>We describe novel phenotypic features including abnormal echocardiogram in nine patients, prominent pain, fatigue and fasciculations. Five patients exhibited executive dysfunction and slowed processing which may be linked to central expression of KCNJ2. We report eight new KCNJ2 variants with in vitro functional data.<\/jats:p>\n                  <jats:p>Our series illustrates that Andersen\u2013Tawil syndrome is not benign. We report marked neuromuscular morbidity and cardiac risk with multisystem involvement. Our key recommendations include proactive genetic screening of all family members of a proband. This is required, given the risk of cardiac arrhythmias among asymptomatic individuals, and a significant subset of Andersen\u2013Tawil syndrome patients have no (or few) dysmorphic features or negative long exercise test. We discuss recommendations for increased cardiac surveillance and neuropsychometry testing.<\/jats:p>","DOI":"10.1093\/brain\/awab445","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T15:16:42Z","timestamp":1639408602000},"page":"2108-2120","source":"Crossref","is-referenced-by-count":20,"title":["Andersen\u2013Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity"],"prefix":"10.1093","volume":"145","author":[{"given":"Vinojini","family":"Vivekanandam","sequence":"first","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roope","family":"M\u00e4nnikk\u00f6","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Skorupinska","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Germain","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Gray","sequence":"additional","affiliation":[{"name":"Cardiovascular Clinical Academic Group, St. George\u2019s, University of London and St. George\u2019s University Hospitals NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wedderburn","sequence":"additional","affiliation":[{"name":"West of Scotland Regional Genetics Service, Queen Elizabeth University Hospital , Glasgow , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Kozyra","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sud","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"James","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Holmes","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Savvatis","sequence":"additional","affiliation":[{"name":"Cardiology Department, St Bartholomew\u2019s Hospital , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Fialho","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashirwad","family":"Merve","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, National Hospital for Neurology and Neurosurgery , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Pattni","sequence":"additional","affiliation":[{"name":"Neuropsychology, National Hospital for Neurology and Neurosurgery , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Farrugia","sequence":"additional","affiliation":[{"name":"West of Scotland Regional Genetics Service, Queen Elizabeth University Hospital , Glasgow , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah R","family":"Behr","sequence":"additional","affiliation":[{"name":"Cardiovascular Clinical Academic Group, St. George\u2019s, University of London and St. George\u2019s University Hospitals NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Marini-Bettolo","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Hanna","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3810-306X","authenticated-orcid":false,"given":"Emma","family":"Matthews","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London , UK"},{"name":"Atkinson-Morley Neuromuscular Centre, Department of Neurology, St George\u2019s University Hospitals NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"2022070101372146600_awab445-B1","volume":"148","author":"Fialho","year":"2018","journal-title":"Periodic Paralysis"},{"issue":"16","key":"2022070101372146600_awab445-B2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","article-title":"Prevalence study of genetically defined skeletal muscle channelopathies in England","volume":"80","author":"Horga","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"2022070101372146600_awab445-B3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2019s syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"issue":"7675","key":"2022070101372146600_awab445-B4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Aguet","year":"2017","journal-title":"Nature"},{"key":"2022070101372146600_awab445-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2013.10.010","article-title":"Andersen\u2013Tawil syndrome: Clinical and molecular aspects","volume":"170","author":"Nguyen","year":"2013","journal-title":"Int J Cardiol"},{"issue":"11","key":"2022070101372146600_awab445-B6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1212\/01.wnl.0000218214.64942.64","article-title":"Andersen\u2013Tawil syndrome: Definition of a neurocognitive phenotype","volume":"66","author":"Yoon","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"2022070101372146600_awab445-B7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"issue":"21","key":"2022070101372146600_awab445-B8","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen\u2013Tawil syndrome patients with KCNJ2 mutations: Characteristic T-U-wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"2022070101372146600_awab445-B9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2020.02.033","article-title":"Natural history and risk stratification in Andersen\u2013Tawil syndrome type 1","volume":"75","author":"Mazzanti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2022070101372146600_awab445-B10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nmd.2004.06.007","article-title":"Expanding the phenotype of potassium channelopathy: Severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia","volume":"14","author":"Manzur","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"18","key":"2022070101372146600_awab445-B11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/01.wnl.0000342387.65477.46","article-title":"Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis","volume":"72","author":"Matthews","year":"2009","journal-title":"Neurology"},{"key":"2022070101372146600_awab445-B12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JND-200572","article-title":"Andersen\u2013Tawil syndrome presenting with complete heart block","author":"Suetterlin","year":"2021","journal-title":"J Neuromuscul Dis"},{"issue":"3","key":"2022070101372146600_awab445-B13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/nutrit\/nuv105","article-title":"Adult height, nutrition, and population health","volume":"74","author":"Perkins","year":"2016","journal-title":"Nutr Rev"},{"issue":"1","key":"2022070101372146600_awab445-B14","first-page":"9","article-title":"Anthropometric survey of the astronaut applicants and astronauts from 1985 to 1991","volume":"1","author":"Rajulu","year":"1977","journal-title":"NASA"},{"key":"2022070101372146600_awab445-B15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/adc.67.10.1286","article-title":"Centiles for adult head circumference","volume":"67","author":"Bushby","year":"1992","journal-title":"Arch Dis Child"},{"issue":"6","key":"2022070101372146600_awab445-B16","doi-asserted-by":"crossref","first-page":"e010364","DOI":"10.1136\/bmjopen-2015-010364","article-title":"Prevalence of chronic pain in the UK: A systematic review and meta-analysis of population studies","volume":"6","author":"Fayaz","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"2022070101372146600_awab445-B17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the Brief Pain Inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"J Pain"},{"issue":"12","key":"2022070101372146600_awab445-B18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/014107680409701204","article-title":"Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001","volume":"97","author":"Gallagher","year":"2004","journal-title":"J R Soc Med"},{"key":"2022070101372146600_awab445-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13030","article-title":"Surgical procedures and non-surgical devices for the management of non-apnoeic snoring: A systematic review of clinical effects and associated treatment costs","volume":"13","author":"Main","year":"2009","journal-title":"Health Technol Assess"},{"issue":"7365","key":"2022070101372146600_awab445-B20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature10370","article-title":"Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2","volume":"477","author":"Hansen","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2022070101372146600_awab445-B21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jhg.2010.2","article-title":"A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen\u2013Tawil syndrome","volume":"55","author":"Chan","year":"2010","journal-title":"J Hum Genet"},{"issue":"11","key":"2022070101372146600_awab445-B22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1212\/01.wnl.0000218214.64942.64","article-title":"Andersen\u2013Tawil syndrome: Definition of a neurocognitive phenotype","volume":"66","author":"Yoon","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"2022070101372146600_awab445-B23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nurt.2007.01.005","article-title":"Management and treatment of Andersen\u2013Tawil Syndrome (ATS)","volume":"4","author":"Sansone","year":"2007","journal-title":"Neurotherapeutics"},{"key":"2022070101372146600_awab445-B24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/europace\/eup097","article-title":"Indications for the use of diagnostic implantable and external ECG loop recorders","volume":"11","author":"Brignole","year":"2009","journal-title":"Europace"},{"issue":"1","key":"2022070101372146600_awab445-B25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-8703(82)90641-X","article-title":"Objective evidence of occult myocardial dysfunction in patients with frequent ventricular ectopy without clinically apparent heart disease","volume":"104","author":"Kennedy","year":"1982","journal-title":"Am Heart J"},{"issue":"5","key":"2022070101372146600_awab445-B26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0025-6196(11)63724-5","article-title":"Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy","volume":"73","author":"Duffee","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"2022070101372146600_awab445-B27","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.566418","article-title":"K+ channels in primary afferents and their role in nerve injury-induced pain","volume":"14","author":"Smith","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"15","key":"2022070101372146600_awab445-B28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.282.15.1427","article-title":"A population-based study of school scoliosis screening","volume":"282","author":"Yawn","year":"1999","journal-title":"J Am Med Assoc"},{"issue":"1","key":"2022070101372146600_awab445-B29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11832-012-0457-4","article-title":"Epidemiology of adolescent idiopathic scoliosis","volume":"7","author":"Konieczny","year":"2013","journal-title":"J Child Orthop"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awab445\/43292283\/awab445.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/6\/2108\/44360336\/awab445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/6\/2108\/44360336\/awab445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T21:41:46Z","timestamp":1656625306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/6\/2108\/6469017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,12,17]]},"published-print":{"date-parts":[[2022,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awab445","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,12,17]]}}}